These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 18392710

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K.
    J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J, Gansauge S, Mattfeldt T.
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [Abstract] [Full Text] [Related]

  • 8. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE.
    Cancer Res; 1994 Jul 01; 54(13):3568-73. PubMed ID: 8012983
    [Abstract] [Full Text] [Related]

  • 9. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, Fukayama M.
    Virchows Arch; 2002 Nov 01; 441(5):437-43. PubMed ID: 12447672
    [Abstract] [Full Text] [Related]

  • 10. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.
    J Clin Gastroenterol; 2006 Oct 01; 40(9):856-62. PubMed ID: 17016145
    [Abstract] [Full Text] [Related]

  • 11. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
    Schoedel KE, Finkelstein SD, Ohori NP.
    Diagn Cytopathol; 2006 Sep 01; 34(9):605-8. PubMed ID: 16900481
    [Abstract] [Full Text] [Related]

  • 12. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K, Hiyama E, Murakami Y, Kanehiro T, Ohge H, Sueda T, Yokoyama T.
    Oncol Rep; 2003 Sep 01; 10(2):277-83. PubMed ID: 12579258
    [Abstract] [Full Text] [Related]

  • 13. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K, Mizumoto K, Fujita H, Yamaguchi H, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M.
    J Pathol; 2006 Sep 01; 210(1):42-8. PubMed ID: 16794990
    [Abstract] [Full Text] [Related]

  • 14. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
    DiGiuseppe JA, Hruban RH, Offerhaus GJ, Clement MJ, van den Berg FM, Cameron JL, van Mansfeld AD.
    Am J Pathol; 1994 May 01; 144(5):889-95. PubMed ID: 8178941
    [Abstract] [Full Text] [Related]

  • 15. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
    Sakai Y, Yanagisawa A, Shimada M, Hidaka E, Seki M, Tada Y, Harada T, Saisho H, Kato Y.
    Hum Pathol; 2000 Jul 01; 31(7):795-803. PubMed ID: 10923915
    [Abstract] [Full Text] [Related]

  • 16. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M, Van Laethem JL, Parma J, De Maertelaer V, Delhaye M, Devière J.
    Endoscopy; 2004 Jun 01; 36(6):535-42. PubMed ID: 15202051
    [Abstract] [Full Text] [Related]

  • 17. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M, Müller P, Mora J, Brinkmann B, Ostwald C, Farré A, Lluis F, Adam U, Stubbe J, Plath F, Nizze H, Hopt UT, Barten M, Capellá G, Liebe S.
    Gastrointest Endosc; 2001 Jun 01; 53(7):734-43. PubMed ID: 11375580
    [Abstract] [Full Text] [Related]

  • 18. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
    Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, Sninsky JJ.
    Cancer Res; 1993 Jun 01; 53(11):2472-4. PubMed ID: 8495407
    [Abstract] [Full Text] [Related]

  • 19. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y, Sogawa K, Yamaguchi T, Sudo K, Nakagawa A, Sakai Y, Ishihara T, Sunaga M, Nezu M, Tomonaga T, Miyazaki M, Saisho H, Nomura F.
    Hepatogastroenterology; 2008 Jun 01; 55(86-87):1824-9. PubMed ID: 19102401
    [Abstract] [Full Text] [Related]

  • 20. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J, Schlehe B, Menke MA, Vogel I, Henne-Bruns D, Klöppel G.
    Cancer; 1999 Apr 15; 85(8):1703-10. PubMed ID: 10223563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.